These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29758589)

  • 21. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
    Li Y; Li D; Wang J; Tang J
    Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
    El Zein S; Djeroudi L; Reynaud S; Guillemot D; Masliah-Planchon J; Frouin E; Nicolas N; Le Loarer F; Daniel C; Delattre O; Pierron G; Watson S
    Genes Chromosomes Cancer; 2022 Apr; 61(4):200-205. PubMed ID: 34877752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
    Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
    Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelioid and Spindle Cell Rhabdomyosarcoma of the Oral Mucosa with FUS Rearrangement.
    Ochsner AR; Foss RD
    Head Neck Pathol; 2022 Sep; 16(3):823-827. PubMed ID: 35353344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review.
    Haug L; Doll J; Appenzeller S; Kunzmann V; Rosenwald A; Maurus K; Gerhard-Hartmann E
    Pathol Res Pract; 2023 Sep; 249():154779. PubMed ID: 37633005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
    Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
    Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraosseous Spindle Cell Rhabdomyosarcoma with
    Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
    Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior.
    Tan GZL; Saminathan SN; Chang KTE; Odoño EG; Kuick CH; Chen H; Lee VKM
    Pathol Int; 2020 Apr; 70(4):234-236. PubMed ID: 31999033
    [No Abstract]   [Full Text] [Related]  

  • 29. EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.
    Panferova A; Sinichenkova KY; Abu Jabal M; Usman N; Sharlai A; Roshchin V; Konovalov D; Druy A
    Cold Spring Harb Mol Case Stud; 2022 Jun; 8(5):. PubMed ID: 35768243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.
    Brunac AC; Laprie A; Castex MP; Laurent C; Le Loarer F; Karanian M; Le Guellec S; Guillemot D; Pierron G; Gomez-Brouchet A
    Pediatr Blood Cancer; 2020 May; 67(5):e28185. PubMed ID: 31965718
    [No Abstract]   [Full Text] [Related]  

  • 31. Myoepithelioma of bone with a novel FUS-POU5F1 fusion gene.
    Puls F; Arbajian E; Magnusson L; Douis H; Kindblom LG; Mertens F
    Histopathology; 2014 Dec; 65(6):917-22. PubMed ID: 25066216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Rare Case Report of Intraosseous Spindle and Epithelioid Rhabdomyosarcoma With
    Si C; Wang Y; Zhu J
    Int J Surg Pathol; 2024 Mar; ():10668969241239676. PubMed ID: 38500382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Intraosseous Spindle Cell Rhabdomyosarcoma: A Case Report in an Unusual Location.
    Plotzke JM; Rabah R; Robinson DR; Edmonds A; Bloom DA; Mody R; Heider A
    Pediatr Dev Pathol; 2024 Jun; ():10935266241257547. PubMed ID: 38845135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of clinical activity with crizotinib in a patient with FUS rearranged rhabdomyosarcoma with ALK protein overexpression.
    Lewin J; Desai J; Smith K; Luen S; Wong D
    Pathology; 2019 Oct; 51(6):655-657. PubMed ID: 31470995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.